Expanding Disease Definitions in Guidelines and Expert Panel Ties to Industry: A Cross-sectional Study of Common Conditions in the United States

PLoS Medicine

Volumn 10, Issue 8, 2013, Pages

  Moynihan, Raymond N ^a   Cooke, Georga P E ^a   Doust, Jenny A ^a   Bero, Lisa ^b   Hill, Suzanne ^c   Glasziou, Paul P ^a  

^a BOND UNIVERSITY   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE PLUS BENAZEPRIL; AMPHETAMINE; ATOMOXETINE; BAPINEUZUMAB; BUDESONIDE PLUS FORMOTEROL FUMARATE; CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; DONEPEZIL; DULOXETINE; FLUTICASONE PROPIONATE; IRBESARTAN; IRON; LOSARTAN; METHYLPHENIDATE; MONTELUKAST; NICOTINIC ACID; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; OLANZAPINE; OMALIZUMAB; PEGINESATIDE; QUETIAPINE; RIVAROXABAN; ROSUVASTATIN; SERTRALINE; SIMVASTATIN; SOLANEZUMAB; TIOTROPIUM BROMIDE; UNINDEXED DRUG; ZAFIRLUKAST; ZIPRASIDONE;

ALZHEIMER DISEASE; ANEMIA; ARTICLE; ASTHMA; ATTENTION DEFICIT DISORDER; BIPOLAR DEPRESSION; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DSM-5; ECONOMIC ASPECT; FINANCIAL MANAGEMENT; HEALTH CARE PERSONNEL; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INDUSTRY; ORGANIZATION; PANEL STUDY; PRACTICE GUIDELINE; UNITED STATES;

EID: 84883217080     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001500     Document Type: Article

References (43)

1. Welch HG, Schwartz LM, Woloshin S (2011) Overdiagnosed: making people sick in the pursuit of health. Boston: Beacon.
2. Hoffman J, Cooper R, (2012) Overdiagnosis of disease: a modern epidemic. Arch Intern Med 172: 1123-1124.
3. Moynihan R, Doust J, Henry D, (2012) Preventing overdiagnosis: how to stop harming the healthy. BMJ 344: e3502.
4. Brody H, Light D, (2011) The inverse benefit law: how drug marketing undermines patient safety and public health. Am J Public Health 101: 399-404.
5. Lo B, Field MJ (2009) Conflict of interest in medical research, education, and practice. Summary. Washington (D.C.): Institute of Medicine National Academies of Science.
6. Norris SL, Holmer HK, Ogden LA, Burda BU, (2011) Conflict of interest in clinical practice guideline development: a systematic review. PloS One 6: e25153 doi:10.1371/journal.pone.0025153.
7. Cosgrove L, Krimsky S, (2012) A comparison of DSM-IV and DSM-5 panel members' financial associations with industry: a pernicious problem persists. PLoS Med 9: e1001190 doi:10.1371/journal.pmed.1001190.
8. IOM (Institute of Medicine) (2011) Clinical practice guidelines we can trust. Washington (D.C.): The National Academies Press.
9. Kung J, Miller RR, Mackowiak PA, (2012) Failure of clinical practice guidelines to meet institute of medicine standards: two more decades of little, if any, progress. Arch Intern Med 172: 1628-1633.
10. Choudry N, Stelfox HT, Detsky A, (2002) Relationships between authors of Clinical Practice Guidelines and the Pharmaceutical Industry. JAMA 287: 1-6.
11. Soni A (2011) Top 10 most costly conditions among men and women, 2008: estimates for the U.S. civilian noninstitutionalized adult population, age 18 and older. Statistical brief #331. Rockville (Maryland): Agency for Healthcare Research and Quality. Available: http://www.meps.ahrq.gov/mepsweb/data_files/publications/st331/stat331.pdf Accessed 13 February 2013.
12. IMS Institute (2011) Use of medicine in the United States Review of 2010. Available: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/IMS%20Institute/Static%20File/IHII_UseOfMed_report.pdf Accessed 13 February 2013.
13. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program (2007) Expert panel report 3: guidelines for the diagnosis and management of asthma. Full report. Washington (D.C.): US Department of Health and Human Services.
14. National Cholesterol Education Program (2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Bethesda (Maryland): National Institutes of Health. National Heart, Lung, and Blood Institute.
15. Reddel HK, Taylor DR, Bateman ED, Boulet L-P, Boushey HA, et al. (2009) An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Resp Crit Care 180: 59-99.
16. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, et al. (2012) American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of artherosclerosis. Endocr Pract 18: 1-78.
17. The Mood Disorders Work group of the fifth edition of the DSM. Membership, proposed changes and disclosures. Available: http://www.dsm5.org/MeetUs/Pages/MoodDisorders.aspx Accessed 19 October 2012.
18. Global Initiative for Chronic Obstructive Lung Disease (2011) Global Strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease. Updated 2011. Global Initiative for Chronic Obstructive Lung Disease, Inc.
19. ADHD and Disruptive Behavior Disorders Work Group of fifth edition of the DSM. Membership, proposed changes, and disclosures. Available: http://www.dsm5.org/MeetUs/Pages/ADHD.aspx. Accessed 19 October 2012.
20. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, et al. (2012) Third universal definition of myocardial infarction. Circulation 126: 2020-2035.
21. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101: 1900-1920.
22. The International Expert Committee (2009) International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 32: 1327-1334.
23. National High Blood Pressure Education Program (2004) The seventh report of the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Complete report. Bethesda (Maryland): US Department of Health and Human Services, National Institutes of Health. National Heart, Lung, and Blood Institute.
24. Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FDR, et al. (2011) Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 342: d3621-d3621.
25. Aaron SD, Vandemheen KL, Boulet L-P, McIvor RA, Fitzgerald JM, et al. (2008) Overdiagnosis of asthma in obese and nonobese adults. CMAJ 179: 1121-1131.
26. Morrow RL, Garland EJ, Wright JM, Maclure M, Taylor S, et al. (2012) Influence of relative age on diagnosis and treatment of attention-deficit/hyperactivity disorder in children. CMAJ 184: 755-762.
27. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, et al. (2002) Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 20: 1117-1122.
28. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, et al. (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 263-269.
29. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, et al. (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 270-279.
30. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, et al. (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 280-292.
31. Global Initiative for Chronic Obstructive Lung Disease (2010) Global strategy for the diagnosis management and prevention of chronic obstructive pulmonary disease. Updated 2010. Global Initiative for Chronic Obstructive Lung Disease, Inc.
32. Rationale for Changes in ADHD in DSM-5 from the ADHD and Disruptive Behavior Disorders Workgroup Updated May 3, 2012. Available: http://www.dsm5.org/ProposedRevisions/Pages/proposedrevision.aspx?rid=383# Accessed 19 October 2012.
33. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease (2012) Kidney International 2(4) August (2) (Supplements).
34. Lurie P, Almeida C, Stine N, Stine A, Wolfe S, (2006) Financial conflict of interest disclosure and voting patterns at food and drug administration advisory committee meetings. JAMA 295: 1921-1928.
35. Schott G, Pachl H, Limbach U, Gundert-Remy U, Ludwig W-D, Lieb K, (2010) The financing of drug trials by pharmaceutical companies and its consequences. Dtsch Arztebl Int 107: 279-285.
36. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L, (2012) Industry sponsorship and research outcome. Cochrane Database of Syst Rev 12: MR000033.
37. Bekelman JE, Li Y, Gross CP, (2003) Scope and impact of financial conflicts of interest in biomedical research. JAMA 289: 454-465.
38. Fletcher S (2008) Continuing education in the health professions: improving healthcare through lifelong learning: chairman's summary of the conference. Josiah Macy Jr Foundation. Available: http://macyfoundation.org/docs/macy_pubs/Macy_ContEd_1_7_08.pdf Accessed 13 February 2013.
39. Wang AT, McCoy CP, Murad MH, Montori VM, (2010) Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ 340: c1344-c1344.
40. Schwartz LM, Woloshin S, (1999) Changing disease definitions: implications for disease prevalence. Analysis of the Third National Health and Nutrition Examination Survey, 1988-1994. Effective Clinical Practice 2: 76-85.
41. About the consensus development program. Office of Disease Prevention, National Institutes of Health. Available: http://prevention.nih.gov/cdp/about.aspx Accessed 13 February 2013.
42. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292-302.
43. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, et al. (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62: 2569-2581.